What Can You Expect at the Measuring Impact in Medical Affairs Summit
The Measuring Impact in Medical Affairs Summit is your opportunity to explore how teams are demonstrating their value as Medical Affairs rapidly evolves into a strategic, impact-driven function. This one-of-a-kind meeting brings together leaders from pharma and biotech to share practical, proven approaches for building meaningful KPIs, adopting AI-enabled tools, and clearly demonstrating the real-world value of Medical Affairs activities.
Across interactive workshops, expert-led sessions, and in-depth case studies, you’ll uncover how high-performing teams:
- Capture high-quality, decision-shaping insights
- Communicate impact effectively to senior leadership
- Strengthen cross-functional alignment to deliver measurable outcomes
From Field Medical and Medical Communications to Evidence Generation and beyond, the summit highlights how every Medical Affairs subfunction can contribute to a unified, outcomes-focused strategy.
Join 50+ senior Medical Affairs professionals from organizations including Regeneron, Boehringer Ingelheim, Abbvie, Alexion, and Travere. Connect with peers, exchange best practices, and walk away with actionable frameworks you can put to work immediately.
Leave equipped to translate data, insights, and scientific engagement into demonstrable impact, and help shape the next generation of Medical Affairs excellence.
Unmissable Event Highlights
From Insight to Outcome: Building a Measurement Framework that Demonstrates True Medical Affairs Impact
Regeneron’s Carl de Luca explores how to move beyond activity‑based metrics to generate high‑quality insights that identify meaningful clinical and educational gaps capable of shaping robust medical strategy.
The Future of Medical Affairs, Evolving from a Support Function to a Strategic Driver of Business & Patient Impact
Merz Therapeutics’ Selena Freisens explores how Medical Affairs is evolving into a data‑led strategic pillar - shaping clinical decisions, commercial impact, and patient outcomes within an increasingly complex healthcare landscape
Bridging the Gap and Turning Scientific Insights into Strategic Action
AbbVie’s Denise Briggs reveals how Medical Affairs teams can systematically capture and share insights across R&D and commercial functions — proving their strategic value through aligned objectives and measurable outcomes.
Attending Companies Include